Cellular and immune landscape of chronic liver diseases: insights from immunophenotyping

Cellular and immune landscape of chronic liver diseases: insights from immunophenotyping

BackgroundChronic liver disease due to alcohol-related liver disease and chronic viral hepatitis pose a substantial burden on healthcare systems. Chronic liver disease may predispose to hepatocellular carcinoma, for which therapeutic options are limited. This study aimed to explore the immune cell c...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shaghayegh Soleimani, Ozgur Albayrak, Kayra Somay, Hong Yang, Buket Yigit, Burge Ulukan, Dila Atak, Murat Akyildiz, Metehan Gursoy, Elif Demirtas, Adil Mardinoglu, Atay Vural, Murat Dayangac, Mujdat Zeybel
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Molecular Biosciences
Subjects:	chronic liver disease hepatitis liver immunophenotyping hepatic inflammation fibrosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fmolb.2024.1521811/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Miliary Tuberculosis Initially Presenting as an Isolated Hepatic Abscess
by: Chang Won Ha, et al.
Published: (2025-01-01)

Demographics, aetiology and outcome of paediatric acute liver failure in Singapore
by: Fang Kuan Chiou, et al.
Published: (2022-11-01)

Risk of progression and the cause of mortality at chronic viral mixed-hepatitis
by: K. I. Yesmembetov, et al.
Published: (2013-07-01)

Magnitude, patterns, and factors associated with liver disease among clinically suspected clients in Eastern Ethiopia: hidden public health tragedy
by: Aliya Nuri, et al.
Published: (2025-01-01)

Prevalence of HDV, HCV, and HIV Infection in the Population of Patients Infected with HBV in a Romanian Cohort
by: Antoanela Curici, et al.
Published: (2025-01-01)

Paracetamol-induced hepatotoxicity in a malnourished patient: A case report
by: Sudhanshu Shukla, et al.
Published: (2024-04-01)

Positive association between proinsulin and fatty liver index in people with type 2 diabetes
by: Akinobu Nakamura, et al.
Published: (2024-02-01)

Efficacy of hepatitis B vaccination in patients awaiting liver transplantation in prophylaxis of <i>de novo</i> HBV-infection of a graft
by: V. Ye. Syutkin, et al.
Published: (2010-04-01)

Acute Viral Hepatitis-B in a COVID-19 Patient with Respiratory Failure
by: Seval SÖNMEZ YILDIRIM, et al.
Published: (2025-02-01)

Evaluation of liver fibrosis in HCV-infected patients using two-dimensional shear-wave elastography (2D-SWE) before and after antiviral treatment
by: Inglot Marcin, et al.
Published: (2024-12-01)

Infection with hepatitis C virus as a cause of cirrhosis – case study
by: Lidia Sierpińska, et al.
Published: (2025-01-01)

Exploration of the Role of Cyclophilins in Established Hepatitis B and C Infections
by: Jennifer Molle, et al.
Published: (2024-12-01)

Characterization of liver, adipose, and fecal microbiome in obese patients with MASLD: links with disease severity and metabolic dysfunction parameters
by: Katherine J. P. Schwenger, et al.
Published: (2025-01-01)

Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA clearance in chronic hepatitis B patients
by: Qiyao Wei, et al.
Published: (2025-02-01)

Fatal acute liver failure following norovirus gastroenteritis in a child: A case report
by: Rabab Taha, et al.
Published: (2025-04-01)

Long-Term Monitoring of Liver Fibrosis and Steatosis in Patients with Chronic Hepatitis C after Achieving a Sustained Virologic Response to Antiviral Therapy
by: K. R. Dudina, et al.
Published: (2023-02-01)

Diastolic dysfunction of myocardium and change of <i>Q–T</i> interval at chronic hepatitis C
by: A. A. Konysheva, et al.
Published: (2012-11-01)

The effect of nuclear transcriptional factor κВ activation inhibitor – curcumine on the experimental immune liver disease
by: I. N. Alekseyeva, et al.
Published: (2010-02-01)

Risk of Cirrhosis in Patients with Non-alcoholic Fatty Liver Disease and Previous Viral Hepatitis B
by: S. N. Batskikh, et al.
Published: (2020-09-01)

Factors associated with early hospital readmission for acute decompensation of cirrhosis - prospective cohort study
by: Tamara Liana Zocche, et al.
Published: (2025-02-01)

Factors associated with early hospital readmission for acute decompensation of cirrhosis - prospective cohort study
by: Tamara Liana Zocche, et al.
Published: (2025-02-01)

Changes in DNA methylation profile in liver tissue during progression of HCV-induced fibrosis to hepatocellular carcinoma
by: I. A. Goncharova, et al.
Published: (2023-03-01)

Screening investigation of patients with diffuse liver diseases
by: I. Yu. Pirogova
Published: (2010-06-01)

Liver macrophage-derived exosomal miRNA-342-3p promotes liver fibrosis by inhibiting HPCAL1 in stellate cells
by: Wenshuai Li, et al.
Published: (2025-02-01)

Propensity Score Matching Analysis for Alcohol‐Related Liver Disease
by: Fangfang Duan, et al.
Published: (2025-01-01)

Key oncogenes and candidate drugs for hepatitis-B-driven hepatocellular carcinoma progression
by: Liqin Ruan, et al.
Published: (2025-02-01)

Lifetime of patients and prognostic value of manifestations and complications of liver cirrhosis
by: G. K. Mirodzhov, et al.
Published: (2010-11-01)

Late Onset Hepatic Encephalopathy after Living Donor Liver Transplant: Successful Reversal by Plug Embolization of Shunt—A Report of Two Cases
by: Shahnawaz Bashir, et al.

Long-Term Results of the Etiotropic Therapy of Subcompensed Liver Cirrhosis in the Outcome of Chronic Hepatitis C
by: P. O. Bogomolov, et al.
Published: (2020-01-01)

Chronic hepatitis C course at elderly and therapeutic approach
by: M. V. Mayevskaya, et al.
Published: (2011-02-01)

DIABETES MELLITUS IN PATIENTS WITH LIVER CIRRHOSIS: NEW TREATMENT OPTIONS
by: L. Yu. Morgunov
Published: (2017-09-01)

Occult hepatitis B virus infection: risk for a blood supply, but how about individuals’ health?
by: Michael X. Fu, et al.
Published: (2025-03-01)

Hepatic encephalopathy and spontaneous bacterial peritonitis are associated with increased liver-related readmissions in cirrhosis
by: Shan Wang, et al.
Published: (2025-01-01)

Spinal cord injury induces transient activation of hepatic stellate cells in rat liver
by: Inmaculada Fernandez-Canadas, et al.
Published: (2025-01-01)

Comparison of CT-Guided Microwave Ablation of Liver Malignancies with and Without Intra-Arterial Catheter Placement for Contrast Administration
by: Anne Bettina Beeskow, et al.
Published: (2025-01-01)

The dynamics of a delay model of hepatitis B virus infection with logistic hepatocyte growth
by: Steffen Eikenberry, et al.
Published: (2009-02-01)

Recent advances in polymeric nanoparticles for the treatment of hepatic diseases
by: Feng Gao, et al.
Published: (2025-01-01)

Clinical Practice Guidelines of the Russian Society for the Study of the Liver, the Russian Gastroenterological Association, the National Scientific Society of Infectious Disease Specialists for the Diagnosis and Treatment of Chronic Hepatitis C
by: V. T. Ivashkin, et al.
Published: (2023-06-01)

Thirteen-Year Follow-Up of a Patient with Liver Cirrhosis Resulting from the Overlap Syndrome of Autoimmune Hepatitis and Primary Biliary Cholangitis: Severe COVID-19 and Liver Transplantation
by: A. Kh. Odintsova, et al.
Published: (2024-03-01)

Inflammatory lipid biomarkers and transplant-free mortality risk in hepatitis B-related cirrhosis and hepatic encephalopathy
by: Ke Shi, et al.
Published: (2025-01-01)